NCT06739759招募中不适用
Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 300
- 试验地点
- 2
- 主要终点
- prevention of OHSS
研究概览
简要总结
Ovarian hyperstimulation is a very hazardous complication of ICSI
详细描述
Ovarian hyperstimulation could be mild , moderate , severe or marked
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 19 Years 至 42 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women with PCOS coming for ICSI
排除标准
- •Women who donnot have PCOS
研究组 & 干预措施
antagonist
Active Comparator
patients with PCOS undergoing ICSI receiving antagonist protocol
干预措施: Antagonist protocol for IVF (Drug)
Modified agonist with additives
Active Comparator
Patients with PCOS undergoing ICSI receiving modified agonist protocol with additives
干预措施: Modified Agonist protocol for IVF with additive treatments as HCQ (Drug)
结局指标
主要结局
prevention of OHSS
时间窗: within 3 weeks
prevention of symptoms of ovarian hyperstimulation syndrome as amount of ascites in litres by US
次要结局
未报告次要终点
研究者
Mahmoud Alalfy
National Research centre
Aljazeera Hospital
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.Ovarian Hyperstimulation Syndrome (OHSS)NCT01703728Ferring Pharmaceuticals455
Unknown
4 期
Comparing Coasting by Withholding GnRH Agonist With GnRH AntagonistIn Vitro FertilizationNCT01347268Shin Kong Wu Ho-Su Memorial Hospital120
终止
4 期
Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?Ovarian Hyperstimulation SyndromeNCT01714648Elisha Hospital6
Unknown
4 期
Preventive Application of GnRH Antagonist on Early OHSSOvarian Hyperstimulation SyndromeGnRH AntagonistAspirinVascular Endothelial Growth FactorPigment Epithelium Derived FactorNCT03188471First Affiliated Hospital, Sun Yat-Sen University175
已完成
不适用
Inositols and FSH in IVFAmount of FSH Units During Ovarian Stimulation ProtocolsNCT04576546Lo.Li.Pharma s.r.l300